נגישות
menu      
חיפוש מתקדם
תחביר
חפש...
הספר "אוצר וולקני"
אודות
תנאי שימוש
ניהול
קהילה:
אסיף מאגר המחקר החקלאי
פותח על ידי קלירמאש פתרונות בע"מ -
Elevated Expression of Moesin in Muscular Dystrophies
Year:
2017
Source of publication :
American Journal of Pathology
Authors :
גנין, אולגה
;
.
לביא, עדי
;
.
לוי, אשרת
;
.
פינס, מרק
;
.
Volume :
187
Co-Authors:

Pines, M., Institute of Animal Sciences, Volcani Center, Bet Dagan, Israel
Levi, O., Institute of Animal Sciences, Volcani Center, Bet Dagan, Israel
Genin, O., Institute of Animal Sciences, Volcani Center, Bet Dagan, Israel
Lavy, A., Institute of Animal Sciences, Volcani Center, Bet Dagan, Israel, Department of Animal Sciences, the Hebrew University of Jerusalem, Rehovot, Israel
Angelini, C., Istituto di Ricovero e Cura a Carattere Scientifico Fondazione Ospedale S. Camillo, Venice, Italy
Allamand, V., Research Center in Myology, UPMC Univ Paris 06-Inserm Unité Mixte de Recherche en Santé 974, Centre National de la Recherche Scientifique Formation de Recherche en Evolution 3617, Institut de Myologie, Groupe Hospitalier Pitié-Salpêtrière, Paris, France
Halevy, O., Department of Animal Sciences, the Hebrew University of Jerusalem, Rehovot, Israel

Facilitators :
From page:
654
To page:
664
(
Total pages:
11
)
Abstract:
Fibrosis is the main complication of muscular dystrophies. We identified moesin, a member of the ezrin-radixin-moesin family, in dystrophic muscles of mice representing Duchenne and congenital muscular dystrophies (DMD and CMD, respectively) and dysferlinopathy, but not in the wild type. High levels of moesin were also observed in muscle biopsy specimens from DMD, Ullrich CMD, and merosin-deficient CMD patients, all of which present high levels of fibrosis. The myofibroblasts, responsible for extracellular matrix protein synthesis, and the macrophages infiltrating the dystrophic muscles were the source of moesin. Moesin-positive cells were embedded within the fibrotic areas between the myofibers adjacent to the collagen type I fibers. Radixin was also synthesized by the myofibroblasts, whereas ezrin colocalized with the myofiber membranes. In animal models and patients' muscles, part of the moesin was in its active phosphorylated form. Inhibition of fibrosis by halofuginone, an antifibrotic agent, resulted in a major decrease in moesin levels in the muscles of DMD and CMD mice. In summary, the results of this study may pave the way for exploiting moesin as a novel target for intervention in MDs, and as part of a battery of biomarkers to evaluate treatment success in preclinical studies and clinical trials. © 2017 American Society for Investigative Pathology
Note:
Related Files :
adult
Animal
animal experiment
Animals
animal tissue
metabolism
Muscular dystrophy
Pathology
quinazolinone derivative
עוד תגיות
תוכן קשור
More details
DOI :
10.1016/j.ajpath.2016.11.013
Article number:
0
Affiliations:
Database:
סקופוס
Publication Type:
מאמר
;
.
Language:
אנגלית
Editors' remarks:
ID:
21985
Last updated date:
02/03/2022 17:27
Creation date:
16/04/2018 23:48
Scientific Publication
Elevated Expression of Moesin in Muscular Dystrophies
187

Pines, M., Institute of Animal Sciences, Volcani Center, Bet Dagan, Israel
Levi, O., Institute of Animal Sciences, Volcani Center, Bet Dagan, Israel
Genin, O., Institute of Animal Sciences, Volcani Center, Bet Dagan, Israel
Lavy, A., Institute of Animal Sciences, Volcani Center, Bet Dagan, Israel, Department of Animal Sciences, the Hebrew University of Jerusalem, Rehovot, Israel
Angelini, C., Istituto di Ricovero e Cura a Carattere Scientifico Fondazione Ospedale S. Camillo, Venice, Italy
Allamand, V., Research Center in Myology, UPMC Univ Paris 06-Inserm Unité Mixte de Recherche en Santé 974, Centre National de la Recherche Scientifique Formation de Recherche en Evolution 3617, Institut de Myologie, Groupe Hospitalier Pitié-Salpêtrière, Paris, France
Halevy, O., Department of Animal Sciences, the Hebrew University of Jerusalem, Rehovot, Israel

Elevated Expression of Moesin in Muscular Dystrophies
Fibrosis is the main complication of muscular dystrophies. We identified moesin, a member of the ezrin-radixin-moesin family, in dystrophic muscles of mice representing Duchenne and congenital muscular dystrophies (DMD and CMD, respectively) and dysferlinopathy, but not in the wild type. High levels of moesin were also observed in muscle biopsy specimens from DMD, Ullrich CMD, and merosin-deficient CMD patients, all of which present high levels of fibrosis. The myofibroblasts, responsible for extracellular matrix protein synthesis, and the macrophages infiltrating the dystrophic muscles were the source of moesin. Moesin-positive cells were embedded within the fibrotic areas between the myofibers adjacent to the collagen type I fibers. Radixin was also synthesized by the myofibroblasts, whereas ezrin colocalized with the myofiber membranes. In animal models and patients' muscles, part of the moesin was in its active phosphorylated form. Inhibition of fibrosis by halofuginone, an antifibrotic agent, resulted in a major decrease in moesin levels in the muscles of DMD and CMD mice. In summary, the results of this study may pave the way for exploiting moesin as a novel target for intervention in MDs, and as part of a battery of biomarkers to evaluate treatment success in preclinical studies and clinical trials. © 2017 American Society for Investigative Pathology
Scientific Publication
You may also be interested in